Perfume is widely used for fragrance, but many people wonder whether it falls under the category of cosmetics. In simple terms, yes perfume is considered a cosmetic because it is applied externally to enhance personal scent and appearance. Unlike skincare or makeup, it doesn’t alter the body’s structure or function, but it plays a key role in personal grooming and self-expression.
What Makes a Perfume a “Cosmetic” Under FDA Law
Is perfume a cosmetic? Yes. Under the FDA’s FD&C Act, perfume is classified as a cosmetic defined as a product “intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance.” Perfume, cologne, and aftershave all qualify under this definition.
The legal test isn’t about what’s in the product. It’s about what the product claims to do.
According to the FDA, if a fragrance product is intended to make the user more attractive or enhance their appearance, it’s a cosmetic. Perfumes, colognes, and aftershaves all meet this standard by default. No government review required before launch. No premarket approval process.
What the FDA does require for cosmetics:
- Accurate labeling with a full ingredient list
- No use of prohibited or restricted substances
- Product safety (the legal responsibility sits with the manufacturer, not the FDA)
The labeling rule has one famous carve-out. Under the Fair Packaging and Labeling Act (FPLA), fragrance formulas are considered trade secrets. A brand can list “Fragrance” as a single ingredient on the label, even if that word represents dozens or hundreds of individual chemical compounds. This is legal. It’s also a point of growing consumer controversy, especially as allergen awareness increases.
When Perfume Stops Being a Cosmetic and Becomes a Drug
This is the part most guides skip entirely.
The line between cosmetic and drug isn’t drawn by formula. It’s drawn by intent specifically, the intent communicated through your marketing, labeling, and product claims.
According to the FDA, a product becomes a drug when it’s “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease” or intended “to affect the structure or function of the body.” That definition applies to fragrance products too.
A claim that your perfume makes someone feel more attractive is a cosmetic claim. A claim that the same perfume reduces anxiety, aids sleep, relieves headaches, or helps with smoking cessation is a drug claim. Same bottle. Different legal universe.
Specific examples the FDA has flagged as drug-territory claims for fragrance products:
- “Helps you fall asleep faster”
- “Relieves tension and stress”
- “An effective aid for quitting smoking”
- “Balances your mood” (context-dependent, but often a trigger)
The FDA evaluates these on a case-by-case basis. Or maybe I should say it this way there’s no bright-line word list. “Calming” used decoratively is less risky than “clinically calming.” But brands operating close to that line without legal counsel are gambling.
Quick Comparison Table
| Product | Classification | Key Factor | Risk if Mislabeled |
| Eau de Parfum (no claims) | Cosmetic | Attractiveness intent | Low |
| “Stress-relief” room spray applied to skin | Drug (likely) | Therapeutic claim | High needs premarket approval |
| Aromatherapy massage oil | Drug or Cosmetic + Drug | Depends on label claims | Medium-High |
| “Unscented” lotion with masking fragrance | Cosmetic | No therapeutic claims | Low |
| Sleep spray marketed for anxiety | Drug | Functional/health claim | Very High |
Most people assume aromatherapy products are automatically cosmetics. The data says otherwise the FDA has explicitly stated that if an aromatherapy product claims to treat or prevent a health condition, it will be regulated as a drug.
How MoCRA (2022) Changed the Rules And What Perfume Brands Must Know Now
For decades, U.S. cosmetic regulation operated under rules written in the 1930s. That changed in December 2022 when President Biden signed the Modernization of Cosmetics Regulation Act (MoCRA) into law the most significant overhaul of U.S. cosmetic regulation in nearly 90 years.
MoCRA doesn’t reclassify perfume. It raises the floor for what “being a cosmetic” requires.
To ensure your perfume brand complies with MoCRA requirements, follow these steps: 1. Register your manufacturing facility with the FDA by December 29, 2023. 2. Submit a full product and ingredient listing for each fragrance SKU. 3. Establish a documented safety substantiation file for each product. 4. Label all cosmetic allergens as required under MoCRA’s new allergen disclosure rules. 5. Implement an adverse event reporting process serious health events must be reported to FDA.
These aren’t optional. Brands that launched before 2023 under old assumptions need to audit their compliance posture.
The allergen labeling requirement is particularly significant for perfumers. The International Fragrance Association (IFRA) released its 51st edition standards in June 2023, covering prohibited ingredients and restricted-use thresholds. The FDA is expected to align its mandatory fragrance allergen list closely with the EU’s existing allergen disclosure framework under EC Regulation 1223/2009.
Some experts argue that MoCRA’s compliance burden disproportionately harms small indie fragrance brands while large multinationals absorb the cost easily. That’s valid for single-founder startups with no regulatory infrastructure. But the consumer protection argument particularly around allergen disclosure is hard to dismiss when fragrance consistently ranks among the top five allergen categories in cosmetic products (Weitnauer Group, 2025).
Cosmetic vs Drug The Practical Labeling Test
Look if you’re launching a fragrance brand and you’re not sure whether your product description crosses a line, here’s what actually works.
Run the “body function test” on every piece of copy you write. Ask: does this claim describe what the scent does to the user’s body or health? If yes, it’s likely a drug claim. If it describes how the user appears, feels about themselves socially, or smells to others, it’s likely a cosmetic claim.
Perfume as cosmetic vs. perfume as drug: A perfume is a cosmetic when claims focus on attractiveness, scent experience, or social appeal. It becomes a drug when claims reference therapeutic effects on the body like reducing anxiety, aiding sleep, or treating any condition. The key difference is whether the product affects appearance or affects body function.
The FDA doesn’t require a brand to use the word “drug” in their marketing to trigger drug classification. Intent is inferred from the totality of messaging label, website, ads, social media, even product name.
I’ve seen conflicting data on where the line sits for terms like “mood-enhancing” some regulatory attorneys treat it as cosmetic territory, others flag it immediately. My read: if “mood-enhancing” is accompanied by any health-adjacent language (sleep, stress, focus, energy), the combined picture almost certainly triggers drug classification. Used alone as a vague sensory descriptor, it’s lower risk but not zero risk.
The Trade Secret Problem Why “Fragrance” on a Label Tells You Almost Nothing
One word. Hundreds of ingredients.
The trade secret exemption that allows brands to list “Fragrance” as a single ingredient exists because fragrance formulas are genuinely complex proprietary blends often developed over years and worth protecting commercially. That protection is legally legitimate.
The problem is transparency. A consumer with a fragrance allergy has no way of knowing from the label whether the product contains the specific compound triggering their reaction. The FDA doesn’t have the same allergen-labeling authority for cosmetics as it does for food.
MoCRA’s new allergen framework is meant to close this gap but implementation is still in progress as of 2025. The FDA was required to propose a fragrance allergen list for mandatory disclosure by June 2024. Whether that list mirrors the EU’s 82 regulated allergens or takes a narrower approach will significantly affect how perfume brands reformulate and relabel.
Conclusion
Perfume clearly fits within the cosmetic category due to its purpose of enhancing a person’s overall appeal without affecting biological functions. Whether it’s a luxury fragrance or an everyday scent, perfumes remain an essential part of modern cosmetic and personal care routines in 2026.
FAQs
Is perfume considered a cosmetic product?
Yes. Under the FDA’s FD&C Act, perfume is officially classified as a cosmetic. It requires no premarket FDA approval but must meet cosmetic safety and labeling standards, including MoCRA requirements introduced in 2022.
What makes a perfume a drug instead of a cosmetic?
When a perfume makes therapeutic claims like reducing stress, aiding sleep, or treating a health condition the FDA may classify it as a drug. Drug classification requires premarket approval, unlike cosmetics.
How do I know if my fragrance claims are drug claims?
Apply the body function test. If your copy describes an effect on body structure or function (sleep, mood disorders, pain), it’s a drug claim. If it describes attractiveness or scent experience, it’s cosmetic territory.
Does perfume need FDA approval before it’s sold?
No, cosmetic perfumes don’t require FDA premarket approval. But under MoCRA (2022), brands must register facilities, submit ingredient listings, and maintain safety documentation. Non-compliance can trigger enforcement action.
What does IFRA have to do with perfume regulation in the US?
IFRA (International Fragrance Association) sets voluntary industry safety standards for fragrance ingredients. While not legally binding in the US, IFRA standards inform FDA expectations and are widely followed by manufacturers to avoid restricted or prohibited ingredient violations.
